Ibex Biosciences

Biopharmaceutical company.

Based in MD

🤖

AI Overview

With $280K in lobbying spend across 9 quarterly filings, Ibex Biosciences is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2023 to 2024.

$280K
Total Spend
2
Years Active
1
Firms Hired
2
Lobbyists Deployed
4
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$180K
2024$100K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Ibex Biosciences disclosed contacting in their lobbying filings.

SENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Education, Foreign Relations, MED

Advocacy related to the development of therapies for various medical issues, particularly for the treatment of Malaria. Advocacy in support of federal funding for a GMP Facility related to biopharmace

Advocacy in support of federal funding for a GMP Facility related to biopharmaceutical development.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.